OL-101

· Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OL-101, covering 2024-11-08 to 2024-11-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) [Phase 1]